- Home
- SNTI vs HERZ Comparison
SNTI vs HERZ Comparison
Compare SNTI & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- HERZ
- Stock Information
- Founded
- SNTI 2016
- HERZ N/A
- Country
- SNTI United States
- HERZ United States
- Employees
- SNTI N/A
- HERZ N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- HERZ Investment Managers
- Sector
- SNTI Health Care
- HERZ Finance
- Exchange
- SNTI Nasdaq
- HERZ Nasdaq
- Market Cap
- SNTI 39.6M
- HERZ 38.8M
- IPO Year
- SNTI N/A
- HERZ N/A
- Fundamental
- Price
- SNTI $1.39
- HERZ $2.44
- Analyst Decision
- SNTI Strong Buy
- HERZ
- Analyst Count
- SNTI 2
- HERZ 0
- Target Price
- SNTI $8.50
- HERZ N/A
- AVG Volume (30 Days)
- SNTI 121.1K
- HERZ N/A
- Earning Date
- SNTI 11-13-2025
- HERZ N/A
- Dividend Yield
- SNTI N/A
- HERZ N/A
- EPS Growth
- SNTI N/A
- HERZ N/A
- EPS
- SNTI N/A
- HERZ N/A
- Revenue
- SNTI N/A
- HERZ N/A
- Revenue This Year
- SNTI N/A
- HERZ N/A
- Revenue Next Year
- SNTI $150.00
- HERZ N/A
- P/E Ratio
- SNTI N/A
- HERZ N/A
- Revenue Growth
- SNTI N/A
- HERZ N/A
- 52 Week Low
- SNTI $1.26
- HERZ N/A
- 52 Week High
- SNTI $16.94
- HERZ N/A
- Technical
- Relative Strength Index (RSI)
- SNTI 39.50
- HERZ 48.84
- Support Level
- SNTI $1.33
- HERZ $2.42
- Resistance Level
- SNTI $1.42
- HERZ $2.51
- Average True Range (ATR)
- SNTI 0.07
- HERZ 0.08
- MACD
- SNTI 0.02
- HERZ -0.01
- Stochastic Oscillator
- SNTI 44.83
- HERZ 21.05
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About HERZ Herzfeld Credit Income Fund Inc. Common Stock
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.